Evaluation of Viral Suppression in Paediatric Populations: Implications for the Transition to Dolutegravir-Based Regimens in Cameroon: The CIPHER-ADOLA Study.
Fokam J, Bouba Y, Ajeh RA, Guebiapsi DT, Essamba S, Zeh Meka AF, Lifanda E, Ada RA, Yakouba L, Mbengono NB, Djomo ARD, Tetang SN, Sosso SM, Babodo JC, Ambomo OFN, Temgoua EM, Medouane C, Atsinkou SN, Mvogo JL, Onana RM, Anoubissi JD, Ketchaji A, Nka AD, Gouissi DA, Ka'e AC, Fainguem NN, Kamgaing RS, Takou D, Tchouaket MCT, Semengue ENJ, Atsama MA, Nwobegahay J, Vuchas C, Nsimen AN, Bille BE, Gatchuessi SK, Ateba FN, Kesseng D, Billong SC, Armenia D, Santoro MM, Ceccherini-Silberstein F, Koki PN, Hamsatou HC, Colizzi V, Ndjolo A, Perno CF, Zoung-Kanyi Bissek AC.
Fokam J, et al. Among authors: vuchas c.
Biomedicines. 2024 Sep 12;12(9):2083. doi: 10.3390/biomedicines12092083.
Biomedicines. 2024.
PMID: 39335597
Free PMC article.